Inhibitory Effects of Tricyclic Antidepressants (TCAs) on Human Cytochrome P450 Enzymes in Vitro: Mechanism of Drug Interaction between TCAs and Phenytoin
- 1 October 2002
- journal article
- research article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Drug Metabolism and Disposition
- Vol. 30 (10), 1102-1107
- https://doi.org/10.1124/dmd.30.10.1102
Abstract
The ability of tricyclic antidepressants (TCAs) to inhibit phenytoin p-hydroxylation was evaluated in vitro by incubation studies of human liver microsomes and cDNA-expressed cytochrome P450s (P450s). The TCAs tested were amitriptyline, imipramine, nortriptyline, and desipramine. Amitriptyline and imipramine strongly and competitively inhibited phenytoinp-hydroxylation in microsomal incubations (estimatedKi values of 5.2 and 15.5 μM, respectively). In contrast, nortriptyline and desipramine produced only weak inhibition. In the incubation study using cDNA-expressed P450s, both CYP2C9 and CYP2C19 catalyzed phenytoinp-hydroxylation, whereas TCAs inhibited only the CYP2C19 pathway. All of the TCAs tested inhibited CYP2D6-catalyzed dextromethorphan-O-demethylation competitively, with estimated Ki values of 31.0, 28.6, 7.9, and 12.5 μM, respectively. The tertiary amine TCAs, amitriptyline and imipramine, also inhibited CYP2C19-catalyzedS-mephenytoin 4′-hydroxylation (estimatedKi of 37.7 and 56.8 μM, respectively). The secondary amine TCAs, nortriptyline and desipramine, however, showed minimal inhibition of CYP2C19 (estimated IC50 of 600 and 685 μM, respectively). None of the TCAs tested produced remarkable inhibition of any other P450 isoforms. These results suggest that TCAs inhibit both CYP2D6 and CYP2C19 and that the interaction between TCAs and phenytoin involves inhibition of CYP2C19-catalyzed phenytoinp-hydroxylation.Keywords
This publication has 29 references indexed in Scilit:
- Five Distinct Human Cytochromes Mediate Amitriptyline N‐Demethylation In Vitro: Dominance of CYP 2C19 and 3A4The Journal of Clinical Pharmacology, 1998
- Inhibition of cytochrome P450 by nefazodone in vitro: studies of dextromethorphan O‐ and N‐demethylationBritish Journal of Clinical Pharmacology, 1996
- Cytochrome P450 Isozymes and Antiepileptic Drug InteractionsEpilepsia, 1995
- Antidepressant Drug Interactions and the Cytochrome P450 SystemClinical Pharmacokinetics, 1995
- Dextromethorphan and Mephenytoin Phenotyping of Patients Treated with Thioridazine or AmitriptylineTherapeutic Drug Monitoring, 1992
- Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactionsChemical Research in Toxicology, 1992
- Enzyme induction and inhibitionPharmacology & Therapeutics, 1990
- Interaction studies with moclobemideActa Psychiatrica Scandinavica, 1990
- A Study of the Interaction Between Omeprazole and Phenytoin in Epileptic PatientsTherapeutic Drug Monitoring, 1990
- Pharmacokinetic Drug Interactions with Phenytoin (Part I)1Clinical Pharmacokinetics, 1990